-
EP2170067
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2170067
| EP2170067 - LIQUIRITIGENIN AND DERIVATIVES AS SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 21.12.2012 Database last updated on 16.07.2024 | Most recent event Tooltip | 21.12.2012 | Application deemed to be withdrawn | published on 23.01.2013 [2013/04] | Applicant(s) | For all designated states Bionovo, Inc. 5858 Horton Street, Suite 375 Emeryville, California 94608 / US | [N/P] |
| Former [2010/14] | For all designated states Bionovo Inc. 5858 Horton Street, Suite 375 Emeryville, California 94608 / US | Inventor(s) | 01 /
COHEN, Isaac 361 La Salle Ave Piedmont, CA 94610 / US | [2010/14] | Representative(s) | Wichmann, Hendrik, et al Wuesthoff & Wuesthoff Patentanwälte und Rechtsanwalt PartG mbB Schweigerstraße 2 81541 München / DE | [N/P] |
| Former [2010/43] | Wichmann, Hendrik, et al Wuesthoff & Wuesthoff Schweigerstrasse 2 81541 München / DE | ||
| Former [2010/14] | Wichmann, Hendrik Isenbruck Bösl Hörschler Wichmann LLP Prinzregentenstrasse 68 81675 München / DE | Application number, filing date | 08771475.4 | 19.06.2008 | [2010/14] | WO2008US67495 | Priority number, date | US20070767380 | 22.06.2007 Original published format: US 767380 | [2010/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2009002802 | Date: | 31.12.2008 | Language: | EN | [2009/01] | Type: | A2 Application without search report | No.: | EP2170067 | Date: | 07.04.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.12.2008 takes the place of the publication of the European patent application. | [2010/14] | Search report(s) | International search report - published on: | US | 30.12.2009 | (Supplementary) European search report - dispatched on: | EP | 12.01.2011 | Classification | IPC: | A61K31/505, A01N43/54 | [2011/05] | CPC: |
A61K31/352 (EP,US);
A61P1/04 (EP);
A61P13/00 (EP);
A61P13/08 (EP);
A61P15/00 (EP);
A61P15/12 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/20 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P43/00 (EP);
A61P5/32 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
A61P9/14 (EP)
(-)
|
| Former IPC [2010/14] | A01N43/54, A61K31/505 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/14] | Title | German: | LIQUIRITIGENIN UND SEINE DERIVATE ALS SELEKTIVE ÖSTROGENREZEPTOR-BETA-AGONISTEN | [2010/14] | English: | LIQUIRITIGENIN AND DERIVATIVES AS SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS | [2010/14] | French: | LIQUIRITIGENINE ET SES DERIVES UTLISES EN TANT QU'AGONISTES BETA SELECTIFS DES RECEPTEURS DES OESTROGENES | [2010/14] | Entry into regional phase | 22.01.2010 | National basic fee paid | 22.01.2010 | Search fee paid | 22.01.2010 | Designation fee(s) paid | 22.01.2010 | Examination fee paid | Examination procedure | 22.01.2010 | Examination requested [2010/14] | 10.08.2011 | Amendment by applicant (claims and/or description) | 14.03.2012 | Despatch of a communication from the examining division (Time limit: M04) | 25.07.2012 | Application deemed to be withdrawn, date of legal effect [2013/04] | 30.08.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/04] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 14.03.2012 | Fees paid | Renewal fee | 26.07.2010 | Renewal fee patent year 03 | 27.06.2011 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.06.2010 | 03 M06 Fee paid on 26.07.2010 | 30.06.2012 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2005208159 (KANG KYUNG S [KR], et al) [X] 1-4,6-15 * claims 14-16 *; | [Y]WO2006107745 (BIONOVO INC [US], et al) [Y] 1-15 * page 2, line 15 * * claims 1-4 * | [X] - MA C J ET AL, "One step isolation and purification of liquiritigenin and isoliquiritigenin from Glycyrrhiza uralensis Risch. using high-speed counter-current chromatography", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V, NL, (20050617), vol. 1078, no. 1-2, doi:DOI:10.1016/J.CHROMA.2005.01.053, ISSN 0021-9673, pages 188 - 192, XP004924213 [X] 1-3,12-14 * page 188, abstract * DOI: http://dx.doi.org/10.1016/j.chroma.2005.01.053 | [X] - SHIN YONG-WOOK ET AL, "In vitro and in vivo antiallergic effects of Glycyrrhiza glabra and its components", PLANTA MEDICA, (200703), vol. 73, no. 3, ISSN 0032-0943, pages 257 - 261, XP002614359 [X] 1-3,12-14 * page 257, abstract * DOI: http://dx.doi.org/10.1055/s-2007-967126 | [X] - OGAWA Y ET AL, "Allergy-preventive flavonoids from Xanthorrhoea hastilis", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO, JP, (20070401), vol. 55, no. 4, doi:DOI:10.1248/CPB.55.675, ISSN 0009-2363, pages 675 - 678, XP008083195 [X] 1,2,12,13 * page 675, left-hand column, Scheme * DOI: http://dx.doi.org/10.1248/cpb.55.675 | [XP] - MAITI ARUP ET AL, "Synthesis and biological evaluation of (+/-)-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer", JOURNAL OF MEDICINAL CHEMISTRY, (200706), vol. 50, no. 12, ISSN 0022-2623, pages 2799 - 2806, XP002614360 [XP] 1,7-9,12 * Scheme 7 * * page 2799, column r, paragraph 2 * DOI: http://dx.doi.org/10.1021/jm070109i | [XY] - ERLUND I, "Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology", NUTRITION RESEARCH, ELSEVIER INC, XX, (20041001), vol. 24, no. 10, doi:DOI:10.1016/J.NUTRES.2004.07.005, ISSN 0271-5317, pages 851 - 874, XP004673654 [X] 1,12 * figure 1 * * page 856, paragraph 2 * [Y] 1-15 DOI: http://dx.doi.org/10.1016/j.nutres.2004.07.005 | [XY] - HAN DAL-HO ET AL, "Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids", BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, (200207), vol. 66, no. 7, ISSN 0916-8451, pages 1479 - 1487, XP002614361 [X] 1,12 * figure 1 * * page 1481, right-hand column, last paragraph * [Y] 1-15 DOI: http://dx.doi.org/10.1271/bbb.66.1479 | International search | [Y]US2007050865 (AYABE SHINICHI [JP]); | [Y]US2006222721 (COHEN ISAAC [US]); | [A]US2006100238 (KELLY GRAHAM E [AU], et al) |